FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shuichiro Shiina

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Livers

Co-author Network

Publications

TOP 3
Ryosuke Tateishi; Haruhiko Yoshida; Masaaki Akahane; Yoshinari Asaoka; Tadashi Goto; Yuji Kondo; Ryota Masuzaki; Hayato Nakagawa; Masao Omata; Kuni Otomo; Jiro Sato; Shuichiro Shiina; Kazuhiko Koike
Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.
Shintaro Mikami; Shuichiro Shiina; Ryosuke Tateishi; Haruhiko Yoshida; Masaaki Akahane; Yoshinari Asaoka; Tadashi Goto; Yuji Kondo; Kazuhiko Koike
Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Shuichiro Shiina; Ryosuke Tateishi; Takuma Teratani; Haruhiko Yoshida; Masatoshi Imamura; Fumihiko Kanai; Naoya Kato; Yukihiro Koike; Shuntaro Obi; Masao Omata; Shinpei Sato; Kazuhiko Koike
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shuichiro Shiina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ryosuke Tateishi; Haruhiko Yoshida; Masaaki Akahane; Yoshinari Asaoka; Tadashi Goto; Yuji Kondo; Ryota Masuzaki; Hayato Nakagawa; Masao Omata; Kuni Otomo; Jiro Sato; Shuichiro Shiina; Kazuhiko Koike
Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.
PloS one 2013;8(4):e59040.
2012: Shintaro Mikami; Shuichiro Shiina; Ryosuke Tateishi; Haruhiko Yoshida; Masaaki Akahane; Yoshinari Asaoka; Tadashi Goto; Yuji Kondo; Kazuhiko Koike
Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Journal of vascular and interventional radiology : JVIR 2012;23(10):1269-75.
2012: Shuichiro Shiina; Ryosuke Tateishi; Takuma Teratani; Haruhiko Yoshida; Masatoshi Imamura; Fumihiko Kanai; Naoya Kato; Yukihiro Koike; Shuntaro Obi; Masao Omata; Shinpei Sato; Kazuhiko Koike
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(9):1434-42.
2012: Koji Uchino; Noriyo Yamashiki; Haruhiko Yoshida; Toru Arano; Yoshinari Asaoka; Kenichiro Enooku; Eriko Goto; Tadashi Goto; Miho Kanda; Yuji Kondo; Ryota Masuzaki; Hayato Nakagawa; Shuntaro Obi; Masao Omata; Shinpei Sato; Takahisa Sato; Shuichiro Shiina; Ryosuke Tateishi; Kazuhiko Koike
Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.
Journal of gastroenterology 2012;47(10):1152-9.
2012: Kazuya Okushin; Masaya Sato; Shuichiro Shiina; Ryosuke Tateishi; Koji Uchino; Haruhiko Yoshida; Yoshinari Asaoka; Kenichiro Enooku; Naoto Fujiwara; Izumi Fukuda; Tadashi Goto; Yuji Kondo; Shintaro Mikami; Tatsuya Minami; Kazuhiko Koike
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal.
Case reports in gastroenterology 2012;6(3):784-9.
2012: Yoko Soroida; Ryosuke Tateishi; Yutaka Yatomi; Hiromitsu Yokota; Haruhiko Yoshida; Kenichiro Enooku; Tadashi Hoshino; Hiroto Kinoshita; Kazuhiko Koike; Ryota Masuzaki; Ritsuko Nagatomo; Hayato Nakagawa; Shuntaro Obi; Ryunosuke Ohkawa; Shigeo Okubo; Takahisa Sato; Yumiko Satoh; Shuichiro Shiina; Hitoshi Ikeda
Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.
Journal of hepatology 2012;57(2):330-6.
2012: Koichi Ogura; Tomotake Okuma; Shuichiro Shiina; Yusuke Shinoda; Takahiro Goto; Hiroshi Kobayashi; Ryoko Miyake; Kozo Nakamura; Hirotaka Kawano
Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor of the femur from hepatocellular carcinoma.
International journal of clinical oncology 2012;17(4):417-21.
2012: Ryosuke Tateishi; Shuichiro Shiina; Kenichiro Enooku; Kazuhiko Koike
[Tumor markers for hepatocellular carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(5):821-7.
2012: Eriko Goto; Tadashi Goto; Hitoshi Ikeda; Jun Imamura; Yuji Kondo; Ryota Masuzaki; Masao Omata; Shuichiro Shiina; Ryosuke Tateishi; Haruhiko Yoshida; Masaaki Akahane; Kazuhiko Koike
Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
Journal of gastroenterology 2012;47(4):477-85.
2012: Shuichiro Shiina; Ryosuke Tateishi; Koji Uchino; Haruhiko Yoshida; Toru Arano; Yoshinari Asaoka; Kenichiro Enooku; Tadashi Goto; Yuji Kondo; Ryota Masuzaki; Hayato Nakagawa; Masao Omata; Takahisa Sato; Kazuhiko Koike
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
The American journal of gastroenterology 2012;107(4):569-77; quiz 578.
2012: Ryota Masuzaki; Hayato Nakagawa; Masao Omata; Shuichiro Shiina; Ryosuke Tateishi; Koji Uchino; Haruhiko Yoshida; Toru Arano; Yoshinari Asaoka; Kenichiro Enooku; Eriko Goto; Tadashi Goto; Hitoshi Ikeda; Yuji Kondo; Kazuhiko Koike
Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography.
World journal of gastroenterology : WJG 2012;18(12):1385-90.
2012: Kenichiro Enooku; Tadashi Goto; Fumihiko Kanai; Yuji Kondo; Ryota Masuzaki; Masao Omata; Shuichiro Shiina; Ryosuke Tateishi; Haruhiko Yoshida; Kazuhiko Koike
Evaluation of molecular targeted cancer drug by changes in tumor marker doubling times.
Journal of gastroenterology 2012;47(1):71-8.
2011: Yotaro Kudo; Shin Maeda; Dai Mohri; Hayato Nakagawa; Osamu Nakajima; Miki Ohta; Masao Omata; Motoyuki Otsuka; Motoko Seto; Shuichiro Shiina; Motohisa Tada; Yasuo Tanaka; Keisuke Tateishi; Keisuke Yamamoto; Shinzo Yamamoto; Haruhiko Yoshida; Yoshinari Asaoka; Yoshihiro Hirata; Hideaki Ijichi; Tsuneo Ikenoue; Yoshihiro Isomura; Fumihiko Kanai; Kazuhiko Koike
Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway.
Journal of hepatology 2011;55(6):1400-8.
2011: Toru Arano; Yoshinari Asaoka; Kenichiro Enooku; Eriko Goto; Tadashi Goto; Hitoshi Ikeda; Yuji Kondo; Ryota Masuzaki; Hayato Nakagawa; Masao Omata; Shuichiro Shiina; Ryosuke Tateishi; Koji Uchino; Haruhiko Yoshida; Kazuhiko Koike
Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.
International journal of cancer. Journal international du cancer 2011;129(9):2226-35.
2011: Hitoshi Ikeda; Yukiko Inoue; Kazuhiko Koike; Yuji Kondo; Yukio Kume; Ryota Masuzaki; Hayato Nakagawa; Takako Nishikawa; Natsuko Ohtomo; Tomoko Ono; Shuichiro Shiina; Yasushi Tanoue; Ryosuke Tateishi; Tomoaki Tomiya; Kenichiro Enooku; Tadashi Goto; Haruhiko Yoshida; Yutaka Yatomi
Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(10):2204-11.
2011: Koji Uchino; Haruhiko Yoshida; Tadashi Goto; Miho Kanda; Yuji Kondo; Ryota Masuzaki; Masao Omata; Shuichiro Shiina; Ryosuke Tateishi; Kazuhiko Koike
Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Cancer 2011;117(19):4475-83.
2011: Tadashi Goto; Jun Imamura; Kazuhiko Koike; Ryota Masuzaki; Takamasa Ohki; Takahisa Sato; Shuichiro Shiina; Ryosuke Tateishi; Haruhiko Yoshida; Kenichiro Enooku; Eriko Goto; Masao Omata
Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.
Hepatology international 2011;5(3):767-73.
2011: Yuji Kondo; Shuichiro Shiina; Ryosuke Tateishi; Toru Arano; Koji Uchino; Kennichiro Enooku; Eriko Goto; Hayato Nakagawa; Ryota Masuzaki; Yoshinari Asaoka; Hajime Fujie; Tadashi Goto; Masao Omata; Haruhiko Yoshida; Kazuhiko Koike
Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(2):197-205.
2011: Fumihiko Kanai; Haruhiko Yoshida; Ryosuke Tateishi; Shinpei Sato; Takao Kawabe; Shuntaro Obi; Yuji Kondo; Makoto Taniguchi; Kazumi Tagawa; Masafumi Ikeda; Chigusa Morizane; Takuji Okusaka; Hitoshi Arioka; Shuichiro Shiina; Masao Omata
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2011;67(2):315-24.
2010: Kiyoshi Hasegawa; Norihiro Kokudo; Shuichiro Shiina; Ryosuke Tateishi; Makuuchi Masatoshi
Surgery versus radiofrequency ablation for small hepatocellular carcinoma: Start of a randomized controlled trial (SURF trial).
Hepatology research : the official journal of the Japan Society of Hepatology 2010;40(8):851-2.
2010: Takeshi Tsujino; Naoki Sasahira; Kenji Hirano; Ryosuke Tateishi; Hiroyuki Isayama; Minoru Tada; Shuichiro Shiina; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Endoscopic management of biliocutaneous fistula after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2010;22(1):53-5.
2009: Takahisa Sato; Ryosuke Tateishi; Haruhiko Yoshida; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Shuntaro Obi; Naoya Kato; Shuichiro Shiina; Takao Kawabe; Masao Omata
Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.
Hepatology international 2009;3(4):544-50.
2009: Hayato Nakagawa; Shin Maeda; Haruhiko Yoshida; Ryosuke Tateishi; Ryota Masuzaki; Takamasa Ohki; Yoku Hayakawa; Hiroto Kinoshita; Minoru Yamakado; Naoya Kato; Shuichiro Shiina; Masao Omata
Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.
International journal of cancer. Journal international du cancer 2009;125(10):2264-9.
2009: Yuji Kondo; Haruhiko Yoshida; Yutaka Tomizawa; Ryosuke Tateishi; Shuichiro Shiina; Kazumi Tagawa; Masao Omata
Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal disease.
AJR. American journal of roentgenology 2009;193(4):964-9.
2009: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Eriko Goto; Takahisa Sato; Takamasa Ohki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Naoya Kato; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Hepatology (Baltimore, Md.) 2009;49(6):1954-61.
2009: T Ohki; Ryosuke Tateishi; Shuichiro Shiina; E Goto; Toshiro Sato; H Nakagawa; R Masuzaki; T Goto; K Hamamura; Fumihiko Kanai; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.
Gut 2009;58(6):839-44.
2009: Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Eriko Goto; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Shinpei Sato; Fumihiko Kanai; Haruhiko Yoshida; Masao Omata
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.
Journal of gastroenterology 2009;44 Suppl 19():142-6.
2009: Shuichiro Shiina
Image-guided percutaneous ablation therapies for hepatocellular carcinoma.
Journal of gastroenterology 2009;44 Suppl 19():122-31.
2008: Yasuo Tanaka; Fumihiko Kanai; Motohisa Tada; Ryosuke Tateishi; Masashi Sanada; Yasuhito Nannya; Miki Ohta; Yoshinari Asaoka; Motoko Seto; Shuichiro Shiina; Haruhiko Yoshida; Takao Kawabe; Osamu Yokosuka; Seishi Ogawa; Masao Omata
Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Journal of hepatology 2008;49(5):746-57.
2008: Miho Kanda; Ryosuke Tateishi; Hideo Yoshida; Takahisa Sato; Ryota Masuzaki; Takamasa Ohki; Jun Imamura; Tadashi Goto; Haruhiko Yoshida; Keisuke Hamamura; Shuntaro Obi; Fumihiko Kanai; Shuichiro Shiina; Masao Omata
Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(9):1256-63.
2008: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Erik Goto; Takahisa Sato; Takamasa Ohki; Tadashi Goto; Hideo Yoshida; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Comparison of liver biopsy and transient elastography based on clinical relevance.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2008;22(9):753-7.
2008: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Hideo Yoshida; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.
Journal of clinical gastroenterology 2008;42(7):839-43.
2008: Y Kondo; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Takao Kawabe; Masao Omata
Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique.
The British journal of surgery 2008;95(8):996-1004.
2008: Hiroshi Igaki; Keiichi Nakagawa; Kenshiro Shiraishi; Shuichiro Shiina; Norihiro Kokudo; Atsuro Terahara; Hideomi Yamashita; Nakashi Sasano; Masao Omata; Kuni Ohtomo
Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
Japanese journal of clinical oncology 2008;38(6):438-44.
2008: Takamasa Ohki; Ryosuke Tateishi; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Noriyo Yamashiki; Haruhiko Yoshida; Fumihiko Kanai; Naoya Kato; Shuichiro Shiina; Hideo Yoshida; Takao Kawabe; Masao Omata
Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(4):459-64.
2008: Hideo Yoshida; Haruhiko Yoshida; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Ryosuke Tateishi; Tadashi Goto; Shuichiro Shiina; Takao Kawabe; Masao Omata
Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.
Hepatology international 2008;2(1):89-94.
2008: Ryota Masuzaki; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Masao Omata
Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
Best practice & research. Clinical gastroenterology 2008;22(6):1137-51.
2007: Noriyo Yamashiki; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Hideo Yoshida; Yuji Kondo; Takamasa Oki; Takao Kawabe; Masao Omata
Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
Journal of gastroenterology and hepatology 2007;22(12):2155-60.
2007: Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Takahisa Sato; Takamasa Ohki; Tadashi Goto; Hideo Yoshida; Shinpei Sato; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Assessing liver tumor stiffness by transient elastography.
Hepatology international 2007;1(3):394-7.
2007: Shuichiro Shiina
Japanese experience in ablation therapies for hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 2():S223-9.
2007: Yukihiro Koike; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Masatoshi Akamatsu; Ryosuke Tateishi; Tomonori Fujishima; Yujin Hoshida; Miho Kanda; Takashi Ishikawa; Yasushi Shiratori; Masao Omata
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion.
Hepatology international 2007;1(2):295-301.
2007: Shuichiro Shiina; Ryosuke Tateishi; Hideo Yoshida; Fumihiko Kanai; Masao Omata
Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
Saudi medical journal 2007;28(6):831-7.
2007: Takamasa Ohki; Ryosuke Tateishi; Shuichiro Shiina; Takahisa Sato; Ryota Masuzaki; Hideo Yoshida; Fumihiko Kanai; Shuntaro Obi; Haruhiko Yoshida; Masao Omata
Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(3):360-7.
2007: Yuji Kondo; Hideo Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Norio Mine; Noriyo Yamashiki; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Mikio Yanase; Haruhiko Yoshida; Masatoshi Akamatsu; Takuma Teratani; Takao Kawabe; Masao Omata
Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2007;22(2):197-203.
2007: Munenori Takata; Takeharu Asano; Hiroshi Yagioka; Hideyuki Miyoshi; Masatoshi Akamatsu; Hiroshi Mitsui; Toshiaki Gunji; Shuichiro Shiina; Toru Akiyama; Masao Omata
[Radiofrequency ablation of liposarcoma liver metastasis].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2007;96(1):144-6.
2007: Naoki Nakamura; Hiroshi Igaki; Hideomi Yamashita; Kenshiro Shiraishi; Masao Tago; Nakashi Sasano; Shuichiro Shiina; Masao Omata; Makuuchi Masatoshi; Kuni Ohtomo; Keiichi Nakagawa
A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC).
Japanese journal of clinical oncology 2007;37(1):38-43.
2006: Ryosuke Tateishi; Shuichiro Shiina; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Noriyo Yamashiki; Hideo Yoshida; Masatoshi Akamatsu; Takao Kawabe; Masao Omata
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Hepatology (Baltimore, Md.) 2006;44(6):1518-27.
2006: Ryosuke Muroyama; Naoya Kato; Haruhiko Yoshida; Motoyuki Otsuka; Masaru Moriyama; Yue Wang; Run-Xuan Shao; Narayan Dharel; Yasuo Tanaka; Miki Ohta; Ryosuke Tateishi; Shuichiro Shiina; Masashi Tatsukawa; Kenichi Fukai; Fumio Imazeki; Osamu Yokosuka; Yasushi Shiratori; Masao Omata
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Journal of hepatology 2006;45(6):805-12.
2006: Tomonori Fujishima; Takashi Ishikawa; Yasushi Shiratori; Miho Kanda; Ryosuke Tateishi; Masatoshi Akamatsu; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Age-related comparison of the profiles of patients with hepatocellular carcinoma.
Hepato-gastroenterology 2006;53(72):913-8.
2006: Hideomi Yamashita; Keiichi Nakagawa; Kenshiro Shiraishi; Masao Tago; Hiroshi Igaki; Naoki Nakamura; Nakashi Sasano; Shuichiro Shiina; Masao Omata; Kuni Ohtomo
External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation.
Journal of gastroenterology and hepatology 2006;21(10):1555-60.
2006: Y Kondo; Haruhiko Yoshida; Shuichiro Shiina; Ryosuke Tateishi; Takuma Teratani; Masao Omata
Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.
The British journal of surgery 2006;93(10):1277-82.
2006: Masatoshi Akamatsu; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Ryosuke Tateishi; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata
Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(5):536-42.
2006: Takuma Teratani; Haruhiko Yoshida; Shuichiro Shiina; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata
Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.
Hepatology (Baltimore, Md.) 2006;43(5):1101-8.
2006: Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Masao Omata
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
Cancer 2006;106(9):1990-7.
2005: Keiichi Nakagawa; Hideomi Yamashita; Kenshiro Shiraishi; Naoki Nakamura; Masao Tago; Hiroshi Igaki; Yoshio Hosoi; Shuichiro Shiina; Masao Omata; Makuuchi Masatoshi; Kuni Ohtomo
Radiation therapy for portal venous invasion by hepatocellular carcinoma.
World journal of gastroenterology : WJG 2005;11(46):7237-41.
2005: Hideo Yoshida; Haruhiko Yoshida; Shuichiro Shiina; Masao Omata
Early liver cancer: concepts, diagnosis, and management.
International journal of clinical oncology 2005;10(6):384-90.
2005: Takayuki Kawakami; Yujin Hoshida; Fumihiko Kanai; Yasuo Tanaka; Keisuke Tateishi; Tsuneo Ikenoue; Shuntaro Obi; Shinpei Sato; Takuma Teratani; Shuichiro Shiina; Takao Kawabe; Takamasa Suzuki; Naoya Hatano; Hisaaki Taniguchi; Masao Omata
Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment.
Proteomics 2005;5(16):4287-95.
2005: Masaaki Akahane; Hisao Koga; Nobuyuki Kato; Haruyasu Yamada; Kazuhito Uozumi; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Kuni Ohtomo
Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.
Radiographics : a review publication of the Radiological Society of North America, Inc 2005;25 Suppl 1():S57-68.
2005: Naoya Kato; Guijin Ji; Yue Wang; Masanori Baba; Yujin Hoshida; Motoyuki Otsuka; Hiroyoshi Taniguchi; Masaru Moriyama; Narayan Dharel; Tadashi Goto; Run-Xuan Shao; Tadashi Matsuura; Keisuke Ishii; Shuichiro Shiina; Takao Kawabe; Masaaki Muramatsu; Masao Omata
Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Hepatology (Baltimore, Md.) 2005;42(4):846-53.
2005: Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
Gastroenterology 2005;129(1):122-30.
2005: Miki Ohta; Keisuke Tateishi; Fumihiko Kanai; Satoshi Ueha; Bayasi Guleng; Miwa Washida; Yasuo Tanaka; Hideaki Ijichi; Tsuneo Ikenoue; Masataka Sata; Tatsuhiko Sudo; Shuichiro Shiina; Takao Kawabe; Kouji Matsushima; Masao Omata
Reduced p38 mitogen-activated protein kinase in donor grafts accelerates acute intestinal graft-versus-host disease in mice.
European journal of immunology 2005;35(7):2210-21.
2005: Noriyo Yamashiki; Ryosuke Tateishi; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Shinpei Sato; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata
Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(5):508-14.
2005: Naoki Sasahira; Minoru Tada; Hideo Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Kenji Hirano; Hiroyuki Isayama; Nobuo Toda; Yutaka Komatsu; Takao Kawabe; Masao Omata
Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation.
Gut 2005;54(5):698-702.
2005: Run-Xuan Shao; Yujin Hoshida; Motoyuki Otsuka; Naoya Kato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Hiroyoshi Taniguchi; Masaru Moriyama; Takao Kawabe; Masao Omata
Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.
World journal of gastroenterology : WJG 2005;11(13):1995-9.
2005: Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
Cancer 2005;103(6):1201-9.
2005: Tomonori Fujishima; Haruhiko Yoshida; Shuntaro Obi; Shuichiro Shiina; Miho Kanda; Ryosuke Tateishi; Masatoshi Akamatsu; Yukihiro Koike; Shinpei Sato; Takuma Teratani; Takao Kawabe; Yasushi Shiratori; Masao Omata
Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.
Journal of gastroenterology 2005;40(3):266-73.
2005: Masatoshi Akamatsu; Takashi Ishikawa; Yasushi Shiratori; Yukihiro Koike; Shuichiro Shiina; Takuma Teratani; Keisuke Hamamura; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Yasuo Imai; Haruhiko Yoshida; Masao Omata
Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence.
Hepato-gastroenterology 2005;52(62):391-7.
2005: Ryosuke Tateishi; Hideo Yoshida; Shuichiro Shiina; H Imamura; K Hasegawa; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Makuuchi Masatoshi; Masao Omata
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
Gut 2005;54(3):419-25.
2005: Shinpei Sato; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Yukihiro Koike; Shuichiro Shiina; Masao Omata
Three-dimensional power Doppler ultrasonography for hepatocellular carcinoma: a comparison with angiography?
Hepato-gastroenterology 2005;52(61):72-5.
2004: Masatoshi Akamatsu; Haruhiko Yoshida; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Ryosuke Tateishi; Masatoshi Imamura; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Takashi Ishikawa; Masao Omata
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(6):625-9.
2004: Takuma Teratani; Haruhiko Yoshida; Yoshida Haruhiko; Shuichiro Shiina; Shiina Shuichiro; Shuntaro Obi; Obi Shuntaro; Shinpei Sato; Sato Shinpei; Yukihiro Koike; Koike Yukihiro; Keisuke Hamamura; Hamamura Keisuke; Masatoshi Akamatsu; Akamatsu Masatoshi; Tomonori Fujishima; Fujishima Tomonori; Yasuo Imai; Imai Yasuo; Takao Kawabe; Kawabe Takao; Yasushi Shiratori; Shiratori Yasushi; Masao Omata; Omata Masao
A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(6):619-24.
2004: Masao Omata; Ryosuke Tateishi; Haruhiko Yoshida; Shuichiro Shiina
Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation.
Gastroenterology 2004;127(5 Suppl 1):S159-66.
2004: Masatoshi Akamatsu; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Ryosuke Tateishi; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Takashi Ishikawa; Yasushi Shiratori; Masao Omata
Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma.
European journal of gastroenterology & hepatology 2004;16(5):459-66.
2004: Yue Wang; Naoya Kato; Yujin Hoshida; Motoyuki Otsuka; Hiroyoshi Taniguchi; Masaru Moriyama; Shuichiro Shiina; Takao Kawabe; Yoichi M Ito; Masao Omata
UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2441-6.
2004: Shin'pei Sato; Yasushi Shiratori; Masatoshi Imamura; Shuntaro Obi; Shuichiro Shiina; Masaaki Akahane; Kuni Ohtomo; Masao Omata
Re-appearance of power Doppler signals in the tumor nodules of hepatocellular carcinoma after transarterial embolization reflects residual viable tumor cells: histological confirmation.
Hepato-gastroenterology 2004;51(55):56-61.
2003: Hirotsugu Watabe; Yasushi Shiratori; Ryosuke Tateishi; Tomonori Fujishima; Masatoshi Akamatsu; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Shinpei Sato; Takuma Teratani; Shuichiro Shiina; Masao Omata
Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Hepato-gastroenterology 2003;50(54):2157-60.
2003: Yukihiro Koike; Keiichi Nakagawa; Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Shinpei Sato; Shuntaro Obi; Takuma Teratani; Keisuke Hamamura; Haruhiko Yoshida; Masao Omata
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
Hepato-gastroenterology 2003;50(54):2035-9.
2003: Yasushi Shiratori; Shuichiro Shiina; Takuma Teratani; Masatoshi Imamura; Shuntaro Obi; Shin'pei Sato; Yukihiro Koike; Haruhiko Yoshida; Masao Omata
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.
Annals of internal medicine 2003;138(4):299-306.
2003: Yasuo Tanaka; Masaki Takayanagi; Yasushi Shiratori; Yasuo Imai; Shuntaro Obi; Ryosuke Tateishi; Miho Kanda; Tomonori Fujishima; Masatoshi Akamatsu; Yukihiro Koike; Keisuke Hamamura; Takuma Teratani; Takashi Ishikawa; Shuichiro Shiina; Masamichi Kojiro; Masao Omata
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.
Journal of gastroenterology 2003;38(3):288-94.
2003: Yue Wang; Naoya Kato; Yujin Hoshida; Hideo Yoshida; Hiroyoshi Taniguchi; Tadashi Goto; Masaru Moriyama; Motoyuki Otsuka; Shuichiro Shiina; Yasushi Shiratori; Yoichi Ito; Masao Omata
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2003;37(1):65-71.
2002: Hideo Yoshida; Naoya Kato; Yasushi Shiratori; Runxuan Shao; Yue Wang; Shuichiro Shiina; Masao Omata
Weak association between SEN virus viremia and liver disease.
Journal of clinical microbiology 2002;40(9):3140-5.
2002: Takuma Teratani; Takashi Ishikawa; Yasushi Shiratori; Shuichiro Shiina; Haruhiko Yoshida; Masatoshi Imamura; Shuntaro Obi; Shinpei Sato; Keisuke Hamamura; Masao Omata
Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy.
Cancer 2002;95(4):816-23.
2002: Masao Akanuma; Haruhiko Yoshida; Makoto Okamoto; Keiji Ogura; Shin Maeda; Yasuo Hata; Shinpei Sato; Shuichiro Shiina; Takao Kawabe; Yasushi Shiratori; Masao Omata
Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.
Hepato-gastroenterology 2002;49(46):1039-44.
2002: Yujin Hoshida; Yasushi Shiratori; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Masao Omata
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.
Hepato-gastroenterology 2002;49(44):451-5.
2002: Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Keisuke Hamamura; Yukihiro Koike; Masao Omata
Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.
Oncology 2002;62 Suppl 1():64-8.
2001: Shuichiro Shiina; Takuma Teratani; Masao Omata
[Quality of life in the treatment of hepatocellular carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():797-800.
2001: Shuntaro Obi; Shuichiro Shiina; Masatoshi Imamura; Takuma Teratani; S Satoh; Yukihiro Koike; Takashi Ishikawa; Masatoshi Akamatsu; Tomonori Fujishima; Ryosuke Tateishi; Masao Omata
[Management of complications associated with local ablation therapy for hepatocellular carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():606-11.
2001: Shuichiro Shiina; Takuma Teratani; Keisuke Hamamura; Shuntaro Obi; Yukihiro Koike
[Radiofrequency ablation for liver tumors].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():592-5.
2001: M Imamura; Shuichiro Shiina; Takuma Teratani; S Obi; S Sato; Y Koike; M Akamatsu; Y Dan; Y Shiratori; Masao Omata
[Percutaneous hepatic infarction therapy (PIT)].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():569-75.
2001: Takashi Ishikawa; Takuma Teratani; Ryosuke Tateishi; Shuichiro Shiina; Masao Omata
[Overview of percutaneous ablation therapy].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():494-500.
2001: Shinpei Sato; Yasushi Shiratori; Masatoshi Imamura; Takuma Teratani; Shuntaro Obi; Yukihiro Koike; Yasuo Imai; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.
Journal of hepatology 2001;35(2):225-34.
2001: T Ishikawa; T Kohno; T Shibayama; Y Fukushima; S Obi; Takuma Teratani; Shuichiro Shiina; Y Shiratori; M Omata
Thoracoscopic thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm.
Endoscopy 2001;33(8):697-702.
2001: Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Keisuke Hamamura; Yukihiro Koike; M Omata
Percutaneous ethanol injection therapy for liver tumors.
European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology 2001;13(2):95-106.
2001: Kenji Hirano; Y Kondo; Takuma Teratani; Shuntaro Obi; Tomonori Fujishima; Yujin Hoshida; Ryosuke Tateishi; Shinpei Sato; Yukihiro Koike; Shuichiro Shiina; Yasuo Imai; Yasushi Shiratori; Masao Omata
Hepatocellular carcinoma depicted as hypoattenuation on CT hepatic arteriography (CTA) and hyperattenuation on CT during arterial portography (CTAP).
Journal of gastroenterology 2001;36(5):346-9.
2001: Yukihiro Koike; Yasushi Shiratori; Shinichi Sato; Shuntaro Obi; Takuma Teratani; Masatoshi Imamura; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.
Cancer 2001;91(3):561-9.
2000: Yukihiro Koike; Yasushi Shiratori; Shinpei Sato; Shuntaro Obi; Takuma Teratani; M Imamura; Keisuke Hamamura; Y Imai; Hideo Yoshida; Shuichiro Shiina; Masao Omata
Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.
Hepatology (Baltimore, Md.) 2000;32(6):1216-23.
2000: Takuma Teratani; Shuichiro Shiina; Shuntaro Obi; Keisuke Hamamura; Yukihiro Koike; Masatoshi Akamatsu; Tomonori Fujishima; Ryosuke Tateishi; Yasuo Imai; Yasushi Shiratori; Masao Omata
[Percutaneous tumor ablation therapy for the advanced stage of HCC].
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(10):1496-500.
2000: Hideo Yoshida; Nobumasa Kato; Yasushi Shiratori; KH Lan; Suzane Kioko Ono-Nita; Z Feng; Shuichiro Shiina; Masao Omata
Poor association of TT virus viremia with hepatocellular carcinoma.
Liver 2000;20(3):247-52.
2000: Keisuke Hamamura; Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Shuntaro Obi; Shinichi Sato; Hideo Yoshida; Masao Omata
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Cancer 2000;88(7):1557-64.
2000: Shuntaro Obi; Yasushi Shiratori; Shuichiro Shiina; Keisuke Hamamura; N Kato; Masatoshi Imamura; Takuma Teratani; Shinpei Sato; Y Komatsu; Takao Kawabe; Masao Omata
Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma.
European journal of gastroenterology & hepatology 2000;12(3):285-90.
1999: Masayuki Matsumura; Yasushi Shiratori; Y Niwa; Toshihiro Tanaka; K Ogura; Taeko Okudaira; Masatoshi Imamura; K Okano; Shuichiro Shiina; Masao Omata
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Journal of hepatology 1999;31(2):332-9.
1999: M Yamagata; Tadahiko Masaki; Taeko Okudaira; Y Imai; Shuichiro Shiina; Yasushi Shiratori; Masao Omata
Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression.
Hepatology (Baltimore, Md.) 1999;29(6):1722-9.
1999: Y Hata; E Hamada; M Takahashi; S Ota; Keiji Ogura; Shuichiro Shiina; Makoto Okamoto; Taeko Okudaira; Takuma Teratani; Shin Maeda; Yuichi Koike; Shinpei Sato; Shuntaro Obi; Takashi Tanaka; Takao Kawabe; Yasushi Shiratori; T Kawase; M Nomura; Masao Omata
Endoscopic variceal ligation is a sufficient procedure for the treatment of oesophageal varices in patients with hepatitis C liver cirrhosis: comparison with injection sclerotherapy.
Journal of gastroenterology and hepatology 1999;14(3):236-40.
1998: M Imamura; Yasushi Shiratori; Shuichiro Shiina; S Sato; Shuntaro Obi; Taeko Okudaira; Takuma Teratani; Nobumasa Kato; M Akahane; Kuni Ohtomo; M Minami; Masao Omata
Power Doppler sonography for hepatocellular carcinoma: factors affecting the power Doppler signals of the tumors.
Liver 1998;18(6):427-33.
1998: Masatoshi Imamura; Y Shiratori; S Sato; Shuntaro Obi; Taeko Okudaira; Takuma Teratani; N Kato; Shuichiro Shiina; Masao Omata
Percutaneous hepatic infarction therapy for hepatocellular carcinoma.
AJR. American journal of roentgenology 1998;171(4):1031-5.
1997: Yasushi Shiratori; Shuichiro Shiina; P Y Zhang; E Ohno; Taeko Okudaira; D A Payawal; Suzane Kioko Ono-Nita; Masatoshi Imamura; Nobumasa Kato; Masao Omata
Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Cancer 1997;80(11):2060-7.
1996: Shuichiro Shiina; Masatoshi Imamura; Shuntaro Obi; Takuma Teratani; Fumihiko Kanai; Nobumasa Kato; Y Niwa; Taeko Okudaira; D A Payawal; R Tateishi; Yasushi Shiratori; Masao Omata
[Percutaneous ethanol injection therapy for small hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(7):835-9.
1996: Y Niwa; Masayuki Matsumura; Yasushi Shiratori; Masatoshi Imamura; Nobumasa Kato; Shuichiro Shiina; Taeko Okudaira; Y Ikeda; T Inoue; Masao Omata
Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1996;23(6):1384-92.
1996: Fumihiko Kanai; Yasushi Shiratori; Y Yoshida; H Wakimoto; H Hamada; Yumi Kanegae; Izumu Saito; Hideo Nakabayashi; Tatsuya Tamaoki; T Tanaka; KH Lan; Nobumasa Kato; Shuichiro Shiina; Masao Omata
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Hepatology (Baltimore, Md.) 1996;23(6):1359-68.
1995: Yasushi Shiratori; Tateo Kawase; R Nakata; M Tanaka; Y Hikiba; K Okano; Masayuki Matsumura; Y Niwa; Yutaka Komatsu; Shuichiro Shiina
Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver.
Digestive diseases and sciences 1995;40(11):2398-406.
1995: Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Nobumasa Kato; Fumihiko Kanai; Taeko Okudaira; Takuma Teratani; G Tohgo; N Toda; M Ohashi
Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1027-33.
1995: Masayuki Matsumura; Y Niwa; Y Hikiba; K Okano; Nobumasa Kato; Shuichiro Shiina; Yasushi Shiratori; Masao Omata
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
Biochemical and biophysical research communications 1995;207(2):813-8.
1994: Yutaka Komatsu; Yasushi Shiratori; Tateo Kawase; N Hashimoto; K Han; Shuichiro Shiina; Masayuki Matsumura; Y Niwa; Nobumasa Kato; M Tada
Role of polymorphonuclear leukocytes in galactosamine hepatitis: mechanism of adherence to hepatic endothelial cells.
Hepatology (Baltimore, Md.) 1994;20(6):1548-56.
1994: Masayuki Matsumura; Y Niwa; Nobumasa Kato; Yutaka Komatsu; Shuichiro Shiina; Takao Kawabe; Tateo Kawase; H Toyoshima; M Ihori; Yasushi Shiratori
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1994;20(6):1418-25.
1994: Y Imai; Takao Kawabe; M Takahashi; Masayuki Matsumura; Yutaka Komatsu; E Hamada; Y Niwa; M Kurita; Shuichiro Shiina; T Shimada
A case of primary gastric choriocarcinoma and a review of the Japanese literature.
Journal of gastroenterology 1994;29(5):642-6.
1994: Yasushi Shiratori; Y Hikiba; E Mawet; Y Niwa; Masayuki Matsumura; Nobumasa Kato; Shuichiro Shiina; M Tada; Yutaka Komatsu; T Kawabe
Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediators.
Biochemical and biophysical research communications 1994;203(3):1398-403.
1994: Yasushi Shiratori; H Takada; K Hai; H Kiriyama; E Mawet; Yutaka Komatsu; Y Niwa; Masayuki Matsumura; Shuichiro Shiina; Tateo Kawase
Effect of anti-allergic agents on chemotaxis of neutrophils by stimulation of chemotactic factor released from hepatocytes exposed to ethanol.
Digestive diseases and sciences 1994;39(7):1569-75.
1994: M Kurita; H Komatsu; Y Hata; Shuichiro Shiina; S Ota; A Terano; T Sugimoto; T Oka; Y Nanba
Pseudomyxoma peritonei due to adenocarcinoma of the lung: case report.
Journal of gastroenterology 1994;29(3):344-8.
1994: M Kurita; Y Niwa; E Hamada; Y Hata; M Oshima; H Mutoh; Shuichiro Shiina; R Nakata; S Ota; A Terano
Churg-Strauss syndrome (allergic granulomatous angiitis) with multiple perforating ulcers of the small intestine, multiple ulcers of the colon, and mononeuritis multiplex.
Journal of gastroenterology 1994;29(2):208-13.
1993: Yasushi Shiratori; H Takada; Y Hikiba; R Nakata; K Okano; Yutaka Komatsu; Y Niwa; Masayuki Matsumura; Shuichiro Shiina; Masao Omata
Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol.
Hepatology (Baltimore, Md.) 1993;18(6):1477-82.
1993: S Ota; Y Hata; A Terano; K Yoshiura; H Hiraishi; Takao Kawabe; H Mutoh; Shuichiro Shiina; T Sugimoto
Roles of Ca2+ and protein kinase C in regulation of prostaglandin E2 release by cultured rabbit gastric epithelial cells.
Digestive diseases and sciences 1993;38(8):1426-34.
1993: Shuichiro Shiina; K Tagawa; Y Niwa; T Unuma; Yutaka Komatsu; K Yoshiura; E Hamada; M Takahashi; Yasushi Shiratori; A Terano
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
AJR. American journal of roentgenology 1993;160(5):1023-8.
1993: Yasushi Shiratori; Tateo Kawase; Shuichiro Shiina; Yutaka Komatsu; Masao Omata
Role of hepatic sinusoidal cells in hepatic injury and fibrosis in the liver.
Gastroenterologia Japonica 1993;28 Suppl 4():102-6; discussion 112-5.
1993: Yasushi Shiratori; M Tananka; Tateo Kawase; Shuichiro Shiina; Yutaka Komatsu; Masao Omata
Quantification of sinusoidal cell function in vivo.
Seminars in liver disease 1993;13(1):39-49.
1992: Yasushi Shiratori; R Nakata; K Okano; Yutaka Komatsu; Shuichiro Shiina; Tateo Kawase; T Sugimoto; Masao Omata; M Tanaka
Inhibition of hepatic metastasis of colon carcinoma by asialo GM1--positive cells in the liver.
Hepatology (Baltimore, Md.) 1992;16(2):469-78.
1992: Yasushi Shiratori; H Takada; K Hai; H Kiriyama; M Tanaka; Yutaka Komatsu; Shuichiro Shiina; Tateo Kawase; K Matsumoto; K Kamii
A mechanism of accumulation and activation of polymorphonuclear cells and macrophages in the liver of alcoholics: production of chemotactic factor by hepatocytes exposed to ethanol.
Journal of hepatology 1992;15(1-2):266-8.
1992: Shuichiro Shiina; Yutaka Komatsu; Takao Kawabe; K Yoshiura; E Hamada; Y Hata; Y Niwa; Tateo Kawase; S Ota; Yasushi Shiratori
Cholestatic hepatocellular carcinoma diagnosed by deposits of Lipiodol and treated by combination of endoscopic retrograde biliary drainage and transcatheter arterial embolization.
Journal of gastroenterology and hepatology 1992;7(2):154-6.
1991: Shuichiro Shiina; K Tagawa; T Unuma; R Takanashi; K Yoshiura; Yutaka Komatsu; Y Hata; Y Niwa; Yasushi Shiratori; A Terano
Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study.
Cancer 1991;68(7):1524-30.
1991: Shuichiro Shiina; H Fujino; T Kawabe; K Tagawa; T Unuma; M Yoneyama; T Ohmori; S Suzuki; M Kurita; Y Ohashi
Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction.
The American journal of gastroenterology 1991;86(7):872-5.
1991: Shuichiro Shiina; H Fujino; Y Uta; K Tagawa; T Unuma; M Yoneyama; T Ohmori; S Suzuki; M Kurita; Y Ohashi
Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
The American journal of gastroenterology 1991;86(7):866-71.
1991: A Terano; R Nakada; H Mutoh; H Hiraishi; S Ota; Shuichiro Shiina; T Shimada; Y Itoh; K Kimura; J Shiga
Characterization of a newly established cell line (JR-St) derived from human gastric signet ring cell cancer, producing tumor markers.
Gastroenterologia Japonica 1991;26(1):7-13.
1991: Shuichiro Shiina; Y Hata; Y Niwa; Yutaka Komatsu; T Tanaka; K Yoshiura; E Hamada; M Ohshima; H Mutoh; M Kurita
Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms.
Gastroenterologia Japonica 1991;26(1):47-50.
1990: Shuichiro Shiina; K Tagawa; T Unuma; H Fujino; Y Uta; Y Niwa; Y Hata; Yutaka Komatsu; Yasushi Shiratori; A Terano
Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients.
AJR. American journal of roentgenology 1990;155(6):1221-6.
1990: Shuichiro Shiina; K Tagawa; T Unuma; H Fujino; Y Uta; Y Hata; Y Niwa; Yasushi Shiratori; A Terano; T Sugimoto
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver.
AJR. American journal of roentgenology 1990;155(3):507-9.
1990: Shuichiro Shiina; K Tagawa; T Unuma; A Terano
Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma.
AJR. American journal of roentgenology 1990;154(5):947-51.
1990: Yasushi Shiratori; M Tanaka; J Umihara; Tateo Kawase; Shuichiro Shiina; T Sugimoto
Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages.
Journal of hepatology 1990;10(1):51-61.
1989: Shuichiro Shiina; H Aoyama; Yasushi Shiratori; Y Hata; Y Niwa; Yutaka Komatsu; H Mutoh; M Kurita; R Nakata; T Shimada
Splenic ablation by percutaneous injection of ethanolamine oleate in dogs: a possible therapy for hypersplenism.
Gastroenterologia Japonica 1989;24(6):740.
1989: Shuichiro Shiina; Kenji Ibukuro
Transcatheter arterial embolization for the treatment of ruptured hepatocellular carcinoma.
AJR. American journal of roentgenology 1989;153(3):658-9.
1989: A Terano; R Nakada; H Hiraishi; S Ota; H Mutoh; T Shimada; Shuichiro Shiina; Y Itoh; J Shiga; T Sugimoto
Establishment of a new cell line derived from human gastric adenocarcinoma, producing tumor markers.
Gastroenterologia Japonica 1989;24(2):219.
1989: Shuichiro Shiina; M Ohshima; H Fujino; H Muto; H Yasuda; T Kawabe; K Tagawa; T Unuma; Kenji Ibukuro; Y Inoue
A case of gallbladder cancer manifesting chylous ascites and chylothorax.
Gastroenterologia Japonica 1989;24(2):209-13.
1989: Shuichiro Shiina; T Kawabe; H Fujino; H Yasuda; K Tagawa; T Unuma
Pseudochylous ascites developed in a patient with chronic renal failure: importance of lipoprotein analysis.
The American journal of gastroenterology 1989;84(3):337-8.
1988: Shuichiro Shiina; H Fujino; H Yasuda; T Kawabe; K Tagawa; T Unuma; M Yoneyama; T Ohmori; S Suzuki
HBs antigen subtypes among acute hepatitis patients in Japan: evidence of imported hepatitis.
The American journal of gastroenterology 1988;83(7):727-9.
1988: Yasushi Shiratori; Tateo Kawase; Shuichiro Shiina; K Okano; T Sugimoto; H Teraoka; S Matano; K Matsumoto; K Kamii
Modulation of hepatotoxicity by macrophages in the liver.
Hepatology (Baltimore, Md.) 1988;8(4):815-21.
1987: Shuichiro Shiina; H Yasuda; H Muto; K Tagawa; T Unuma; Kenji Ibukuro; Y Inoue; R Takanashi
Percutaneous ethanol injection in the treatment of liver neoplasms.
AJR. American journal of roentgenology 1987;149(5):949-52.
1987: Shuichiro Shiina; T Unuma; T Omori
Protection by low-titer anti-HBs against HBe antigen-positive blood transfusion.
The American journal of gastroenterology 1987;82(9):916-7.